ABSTRACT
Cluster Analysis of mRNA Expression Levels Identifies Multiple Sequential Patterns Following Focal Cerebral Ischemia mRNA Ekspresyon Düzeylerinin Kümeleme Analizi Fokal Serebral İskemi Sonrasında Çoklu Dizisel Paternler Tanımlamaktadır

InTRoduCTIon
With regards to the duration of open time window to treat acute brain ischemia, several methodologies are available for its treatment, including thrombolysis, hemodilution, and vascular reconstructive surgery, in addition to treating vital conditions. These therapies help to maintain or increase cerebral blood flow (CBF), but do not trigger intracellular genetic cascades. However, once CBF falls below the threshold, several genetic cascades are believed to get activated in neurons, resulting in necrosis or apoptosis. Therefore, because the current treatments for acute brain ischemia are limited to blocking the source of the stream, the therapeutic time window is still very small.
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To increase the therapeutic window time, the downstream cascades must be stopped in order to prevent progression to necrotic or apoptotic processes. Analysis of gene expression levels after ischemia can provide valuable information regarding this issue. There are several molecular mechanisms associated with ischemic neuronal death, including spreading depression (SD), calcium influx, apoptosis, inflammation, oxidative stress, cell-cycle disorders, the expression of immediate early genes, proto-oncogenes, and heat shock proteins, etc. Researchers should be aware of the time at which genes are expressed after the onset of cerebral ischemia, since they may help them directly target those genes using therapeutic agents.
The slower the currency of the stream is, the better scanning of its contents such as genetic changes is. We previously reported an experimental model of focal cerebral ischemia induced by KCl, resulting in venous occlusion with SD. This model demonstrates slowly progressive and reproducible infarction (7) (8) . We believe that this model is suitable for gene expression analysis following focal cerebral ischemia. However, because the number of induced SDs in this model can cause variations of the infarction volume (7) (8) , SD should only be induced when attempting to reproduce homogenous infarcts.
To detect the patterns of gene expression following focal cerebral ischemia, we performed the two-vein occlusion method on rats and analyzed the mRNA expression levels of 13 representative genes, including the following: c-fos, c-jun, p53, c-myc, bcl-2, bcl-xL, bax, bad, superoxide dismutase (SOD)-1 and -2, cyclin D1, heme oxygenase-1 (HO-1), and cyclooxygenase (COX)-2.
MATERIAL and METHodS
This study was conducted after obtaining a consent from the German animal protection legislation and has been reviewed by the regional ethics committee (Bezirksregierung Rheinhessen-Pfalz).
Animal Preparation
The experiments were conducted on 25 male Wistar rats (mean body weight: 342 g; range: 280-400 g; Charles River, Germany). The rats were housed in individual cages and were allowed free access to food and water before and after surgery. They were anesthetized using ether and an intraperitoneal injection of 0.5 mg atropine. Anesthesia was maintained using chloral hydrate (12 mg/100 g body weight), which was administered every one hour using a peritoneal catheter. The trachea was intubated in each animal using a silicon tube (2.5 mm o.d.), and the animals were mechanically ventilated with 30% oxygen using a rodent ventilator (Model 683; Harvard Apparatus, South Natick, MA, USA) under the control of end-expiratory PCO 2 monitor (Artema MM206C; Heyer, Sweden). Rectal body temperature was maintained close to 37.0° C throughout the experiment using a feedbackcontrolled heating pad (Harvard Apparatus). Polyethylene catheters (0.96 mm o.d., Portex) were inserted into the right femoral artery and vein. The arterial line allowed continuous monitoring of the mean arterial blood pressure (MABP) and arterial blood gas levels, and the venous line allowed the administration of additional fluids and drugs. PaO 2 , PaCO 2 , arterial pH, and electrolytes were measured using a blood gas and electrolyte analyzer (ABL System 615; Radiometer, Copenhagen, Denmark). Blood pressure was continuously recorded using a pressure transducer (Datascope 870 Monitor & Pressure Display Module; Datascope Corp., Paramus, NJ, USA). All the rats were placed in a stereotaxic frame before handling (Stoelting, Wood Dale, IL, USA). After making a 2.0-cm midline incision in the skin, a window was made to access the right frontoparietal region of the brain surface using a high-speed drill and an operating microscope (OPMicroscope; Zeiss, Wetslar, Germany). During craniectomy, the drill tip was continuously cooled using physiologic saline to avoid thermal injury to the cortex.
Cortical Vein Occlusion via Photochemical Thrombosis
Occlusion of the two adjacent cortical veins was induced using rose bengal dye (Sigma, St. Louis, MO, USA) under fiberoptic illumination by a 50-W mercury lamp (6500-7500 lx, 540 nm) connected via a 100-µm fiber. Only animals with similar venous anatomies (i.e., two prominent adjacent veins connected to the superior sagittal sinus) were used. The diameter of the occluded veins was approximately 100 µm. Rose bengal dye (50 mg/kg body weight) was slowly injected to avoid affecting the systemic arterial pressure, and care was taken to avoid illumination of tissues and other vessels near the target vein. The vein was illuminated for 10 min using a micromanipulator-assisted light guide. To occlude the second vein, half of the initial rose bengal dye was intravenously injected before the new target was illuminated. A photograph of the brain surface and a schematic drawing of the experimental set-up are shown in Figure 1A , B.
Impedance Measurement
Impedance electrodes were prepared using two stainless steel wires (0.5 mm) covered with polyvinyl chloride for electrical insulation (except for the 0.3-mm sharp-pointed tip). The electrodes were implanted into the cortex (0.4-0.5 mm deep and 2.0 mm apart) ( Figure 1 ). Impedance was measured at 1 kHz (10 mV, bias-free) throughout the experiment using a precision LCR monitor (4282A; Hewlett-Packard, USA).
Induction of Cortical SD
KCl was directly administrated to the cerebral cortex of each rat in the ischemic group. The KCl injector, a glass micropipette filled with 150 mmol/L KCl solution, was inserted into the lateral parietal cortex. The injector was connected to a microinjection pump (CMA/100; Carnegie Medicine, Stockholm, Sweden) ( Figure 1A , B).
After establishing stable impedance values, impedance was measured for 25 min. The veins in the rats of the ischemic group were occluded during this time period. Thereafter, the clock was set to 0 min. The rats received 10 injections of
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KCl solution (2.0 µl; delivered at a rate of 10 µL/min) into the parietal cortex at 7, 14, 21, 28, 35, 42, 49, 56, 63, and 70 min.
Brain Tissue Removal
After the acute experiment, the incisions were closed using silk sutures. The rats were returned to their individual cages and allowed free access to water and food, following which they were decapitated under anesthesia with chloral hydrate Three-mm thick coronal sections were obtained from the parietal regions. A 3-mm cubic piece of the cerebral cortex from the region between the occluded veins was separated from the coronal section of each hemisphere ( Figure 1A,B) .
The ipsi-and contralateral samples were frozen using liquid nitrogen. This was performed within 5 min after decapitation. Tissues were stored at -70° C until reverse transcriptase polymerase chain reaction (RT-PCR) analysis was performed.
Semi-quantitative RT-PCR
To analyze mRNA expression levels, the total cellular RNA was extracted from the cortical tissues using the RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. After homogenizing the tissues (20-50 mg) in a lysis buffer, [Remark 1] 70% ethanol was added, and the samples were placed in RNeasy spin columns and centrifuged (15,000 rpm for 1 min). RNA was then washed with buffer RW1 and incubated with RNase-free DNase I (Qiagen) at room temperature for 15 min. After another wash with RW1, RNA was washed twice with buffer RPE and eluted in RNase-free H 2 O. The yield and integrity of each RNA sample was determined by spectrophotometric measurement at A260 and agarose gel electrophoresis, respectively. After destroying any secondary structures (at 70° C for 10 min), RNA was reverse-transcribed in a 20-µL reaction mixture (at 42° C for 1 h) using oligo (dT) primers and the Reverse Transcription System (Promega, USA). The reaction was terminated by heat treatment (95° C for 5 min). Three cDNA dilutions were then amplified by PCR using Taq DNA polymerase (Gibco BRL). After the first denaturation step (95° C for 2 min), PCR amplification was performed for 21-33 cycles (95° C for 30 s, 58-61° C for 30 s, and 72° C for 1 min), followed by a final extension step (72° C for 5 min). The primer sequences and annealing temperatures of the target genes are shown in Table I .
The amplified cDNA products were separated by electrophoresis on a 1.5% agarose gel containing SYBR Gold (1: 10,000; Molecular Probes, USA). The intensities of the PCR products were quantified using an imaging program (ImageQuant, Molecular Dynamics, USA). The intensities of the targeted PCR products were normalized to those of the respective PCR products of the housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase.
To determine how mRNA expression in the treated brain hemisphere is regulated compared to the contralateral side, ratios (ipsilateral/contralateral) of the normalized intensities were calculated.
Statistical Analysis
Data were expressed as the means ± standard deviations. Differences were statistically evaluated using the t-test for two-group comparisons or analysis of variance (ANOVA) for multi-group comparisons. All analyses were performed using statistical software (SigmaPlot 11.0; Systat Software, Chicago, IL, USA). Results were considered statistically significant with an error probability of p <0.05. Cluster analysis was performed 
RESuLTS
Physiological Variables and Impedance
No statistical differences were observed in the physiological data regarding blood gas and electrolyte levels, either before or after cortical vein occlusion. All physiological data were within the normal range (Table II) . Impedance data from typical experiments are shown in Figure 2 . Cortical impedance was stable under baseline conditions in all of the tested rats. Within 60-120 s after the KCl injection into the cortex, a single SD episode was observed for 60-180 s. In some cases, spontaneous SDs occurred, especially in the ischemic group. The total number of both induced and spontaneous SDs was significantly different between the two groups (control group: 0.3 ± 0.5; ischemic group: 13.1 ± 2.7; p < 0.05).
Sequential Changes in Gene Expression after Ischemia and SD
Changes in gene expression that occurred after 10 episodes of ischemia-induced SD are shown in Figure 3 . The c-fos mRNA expression was highly induced at 2 h (80.6 ± 82.1),
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but rapidly decreased within 8 h post-ischemia, reaching statistical significance at 24 h (1.1 ± 0.6, p < 0.05). COX-2 mRNA expression resembled the pattern of c-fos mRNA expression. COX-2 mRNA expression was highly induced within 2 h (14.3 ± 10.4), but rapidly decreased by 8 h, reaching significance at 24 h (0.6 ± 0.2, p < 0.05).
The expression levels of genes in the bcl-2 family were also slightly increased. The bcl-2 mRNA expression was increased at 2 h (2.7 ± 2.7), decreased by 8 h (0.6 ± 0.2) gradually increasing until 72 h (1.3 ± 0.8) post-ischemia. The bcl-xL mRNA expression gradually increased with time, and the expression of this gene at 72 h post-ischemia (1.5 ± 0.3) was significantly higher than that measured at 2 h post-ischemia (0.9 ± 0.2, p < 0.05). HO-1 mRNA expression at 72 h post-ischemia was significantly higher than that measured at 24 h post-ischemia , and 72 h post-surgery for each group; results determined using one-way ANOVA.
(7.4 ± 6.4 vs. 0.9 ± 0.1, p < 0.05). The mRNA expression levels of other genes (e.g., c-jun, c-myc, bax, bad, SOD-1, SOD-2, p53, and cyclin D1) showed no significant differences at 2, 8, 24, and 72 h post-ischemia in the ischemic group.
Cluster Analysis of Gene Expression Levels after Ischemia and SD
The dendrogram (Figure 4) of related genes at different time points post-ischemia reveals a close link between early (2 and 8 h) and late (24 and 72 h) changes. Early correlations were observed between COX-2, c-fos, and bcl-2 (group A); c-jun, SOD-1, bad, p53, SOD-2, bcl-xL, and bax (group B); and cyclin D1, c-myc, and HO-1 (group C).
dISCuSSIon
By artificially inducing slowly progressing focal cerebral ischemia, we divided the 13 representative genes into three groups based on the observed sequential patterns in mRNA expression: early, stable, and late expression groups. Different patterns of gene expression would require different therapeutic approaches. For example, if a neurotoxic gene is expressed in the early phase of ischemia, the proper therapy should inhibit mRNA expression, or the protein that is biosynthesized from the mRNA, in order to block ischemic tissue damage. On the contrary, a gene that is expressed in a late phase and protects tissue from ischemic damage might prevent further ischemic damage.
Three genes, c-fos, COX-2, and HO-1, showed significant expression levels at some phase of this experiment. In the early phase, COX-2 and c-fos peaked within 2 h post-ischemia, while in the late phase HO-1 peaked at 72 h post-ischemia. These three genes are possible therapeutic targets that could be further developed to treat acute brain ischemia.
First, the inhibition of COX-2 expression following hyperacute brain ischemia could increase following ischemic neuronal damage. The enzyme COX-2 has well-known neurotoxic effects that occur after cerebral ischemia and produce prostaglandins and thromboxanes (5, 10, 12) . Aspirin, a nonspecific inhibitor of COX, prevents the onset of ischemic stroke (14) (15) . It is commonly believed that the pharmacological action of aspirin to prevent cerebral ischemia is due to its antiplatelet effect (11) . The abovementioned experimental studies suggest that aspirin could act via neuroprotective effects. According to our results, after focal cerebral ischemia the expression of COX-2 occurs so early that immediate intervention of this gene by administration of antisense in a hyperacute phase would prevent ischemic tissue damage.
In addition, it must be determined if c-fos needs to be controlled while treating acute brain ischemia. This study shows that c-fos mRNA significantly increases during the hyperacute phase after focal cerebral ischemia. Needless to say, c-fos is an immediate early gene (IEG) that is activated immediately after certain kinds of cellular insults, as well as following focal cerebral ischemia (1, 6) . IEGs play key roles in starting many genetic cascades. Therefore, it is unlikely that c-fos has a purely neuroprotective effect, even though a previous study reported that the administration of the antisense oligonucleotide to c-fos mRNA aggravated tissue damage after focal cerebral ischemia (16). For these reasons, the manipulation of c-fos would have its pros and cons.
Third, if the expression of HO-1 mRNA can be pushed forward, ischemic brain damage might be alleviated. HO-1 is a heat shock-or stress-inducible protein. Focal brain ischemia can also induce HO-1(4, 13). Moreover, HO-1 has shown protective effects against cerebral ischemia (9, 13) . In addition, because the results of this study indicate that there is some delay in the expression of HO-1 following ischemic events, if HO-1 could be coercively expressed in the acute phase of ischemia it could be used in potential treatments against ischemic damage.
To summarize, different genes display different patterns of expression following brain ischemia. By monitoring oligonucleotide microarrays of approximately 30,000 transcripts after global transient ischemia in rat brain, it was determined that the immediate response to transient ischemia is mediated by the induction of specific transcription factors and stress genes (2) . Delayed gene expression was characterized by inflammation and a delayed response by immune-related genes. These results suggest that the brain's response to ischemia is an active, specific, and coordinated process. The study is in accordance with the results presented here, regarding the fact that different kinds of genes have different patterns of expression.
SuMMARY
In conclusion, we were able to divide 13 representative genes into three groups based on sequential patterns of mRNA expression: early, stable, and late expression. Three genes, c-fos, COX-2, and HO-1, showed significant expression levels in this experiment. In the early phase, the expression levels of c-fos and COX-2 peaked within 2 h post-ischemia. In the late phase, HO-1 peaked at 72 h. These results may help to develop a novel genetic treatment for acute cerebral ischemia by widening the time window available for treatment.
